A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design.

Craig LaForceFrank C Albers Mark CooperAnna DanilewiczLynn DunsireRobert ReesChristy Cappelletti

Published in: Journal of asthma and allergy (2024)

BATURA evaluates as-needed albuterol-budesonide in participants with mild asthma. The decentralized study model enables the trial to move out of research sites into participant homes, reducing participant burden and improving access.

Keyphrases

phase iii
chronic obstructive pulmonary disease
lung function
phase ii
open label
allergic rhinitis
clinical trial
double blind
study protocol
air pollution